PortfoliosLab logo
IOVA vs. IDYA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between IOVA and IDYA is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

IOVA vs. IDYA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Iovance Biotherapeutics, Inc. (IOVA) and IDEAYA Biosciences, Inc. (IDYA). The values are adjusted to include any dividend payments, if applicable.

-100.00%-50.00%0.00%50.00%100.00%150.00%200.00%December2025FebruaryMarchAprilMay
-81.82%
62.47%
IOVA
IDYA

Key characteristics

Sharpe Ratio

IOVA:

-1.02

IDYA:

-1.05

Sortino Ratio

IOVA:

-2.14

IDYA:

-1.82

Omega Ratio

IOVA:

0.76

IDYA:

0.80

Calmar Ratio

IOVA:

-0.79

IDYA:

-0.84

Martin Ratio

IOVA:

-1.59

IDYA:

-1.57

Ulcer Index

IOVA:

48.67%

IDYA:

36.92%

Daily Std Dev

IOVA:

74.92%

IDYA:

53.52%

Max Drawdown

IOVA:

-99.37%

IDYA:

-74.64%

Current Drawdown

IOVA:

-98.01%

IDYA:

-61.43%

Fundamentals

Market Cap

IOVA:

$1.17B

IDYA:

$1.79B

EPS

IOVA:

-$1.28

IDYA:

-$3.36

PS Ratio

IOVA:

7.12

IDYA:

256.10

PB Ratio

IOVA:

1.65

IDYA:

1.73

Total Revenue (TTM)

IOVA:

$163.35M

IDYA:

$7.00M

Gross Profit (TTM)

IOVA:

$41.24M

IDYA:

$5.26M

EBITDA (TTM)

IOVA:

-$255.01M

IDYA:

-$274.69M

Returns By Period

In the year-to-date period, IOVA achieves a -57.16% return, which is significantly lower than IDYA's -29.26% return.


IOVA

YTD

-57.16%

1M

11.23%

6M

-74.19%

1Y

-76.33%

5Y*

-38.62%

10Y*

-11.50%

IDYA

YTD

-29.26%

1M

25.38%

6M

-39.38%

1Y

-56.10%

5Y*

21.60%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

IOVA vs. IDYA — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IOVA
The Risk-Adjusted Performance Rank of IOVA is 44
Overall Rank
The Sharpe Ratio Rank of IOVA is 44
Sharpe Ratio Rank
The Sortino Ratio Rank of IOVA is 22
Sortino Ratio Rank
The Omega Ratio Rank of IOVA is 44
Omega Ratio Rank
The Calmar Ratio Rank of IOVA is 66
Calmar Ratio Rank
The Martin Ratio Rank of IOVA is 55
Martin Ratio Rank

IDYA
The Risk-Adjusted Performance Rank of IDYA is 55
Overall Rank
The Sharpe Ratio Rank of IDYA is 33
Sharpe Ratio Rank
The Sortino Ratio Rank of IDYA is 44
Sortino Ratio Rank
The Omega Ratio Rank of IDYA is 66
Omega Ratio Rank
The Calmar Ratio Rank of IDYA is 44
Calmar Ratio Rank
The Martin Ratio Rank of IDYA is 66
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

IOVA vs. IDYA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Iovance Biotherapeutics, Inc. (IOVA) and IDEAYA Biosciences, Inc. (IDYA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current IOVA Sharpe Ratio is -1.02, which is comparable to the IDYA Sharpe Ratio of -1.05. The chart below compares the historical Sharpe Ratios of IOVA and IDYA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.50-1.00-0.500.000.501.001.502.00December2025FebruaryMarchAprilMay
-1.02
-1.05
IOVA
IDYA

Dividends

IOVA vs. IDYA - Dividend Comparison

Neither IOVA nor IDYA has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

IOVA vs. IDYA - Drawdown Comparison

The maximum IOVA drawdown since its inception was -99.37%, which is greater than IDYA's maximum drawdown of -74.64%. Use the drawdown chart below to compare losses from any high point for IOVA and IDYA. For additional features, visit the drawdowns tool.


-90.00%-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%December2025FebruaryMarchAprilMay
-93.97%
-61.43%
IOVA
IDYA

Volatility

IOVA vs. IDYA - Volatility Comparison

Iovance Biotherapeutics, Inc. (IOVA) has a higher volatility of 26.25% compared to IDEAYA Biosciences, Inc. (IDYA) at 21.22%. This indicates that IOVA's price experiences larger fluctuations and is considered to be riskier than IDYA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%December2025FebruaryMarchAprilMay
26.25%
21.22%
IOVA
IDYA

Financials

IOVA vs. IDYA - Financials Comparison

This section allows you to compare key financial metrics between Iovance Biotherapeutics, Inc. and IDEAYA Biosciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00M40.00M60.00M80.00M20212022202320242025
73.69M
0
(IOVA) Total Revenue
(IDYA) Total Revenue
Values in USD except per share items